In vivo molecular chemotherapy and noninvasive imaging with an infectivity-enhanced adenovirus

Journal of the National Cancer Institute

Volumn 94, Issue 10, 2002, Pages 741-749

  Hemminki, Akseli ^a,d   Zinn, Kurt R ^b   Liu, Bin ^a   Chaudhuri, Tandra R ^b   Desmond, Renee A ^a   Rogers, Buck E ^c   Barnes, Mack N ^a   Alvarez, Ronald D ^a   Curiel, David T ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b University of Alabama at Birmingham   (United States)

^c The University of Alabama at Birmingham   (United States)

^d University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; LUCIFERASE; RECEPTOR SUBTYPE; SOMATOSTATIN DERIVATIVE; SOMATOSTATIN RECEPTOR; TECHNETIUM 99M; THYMIDINE KINASE; VIRUS RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER SURVIVAL; CONTROLLED STUDY; COXSACKIE VIRUS; DRUG EFFICACY; EXPERIMENTAL MODEL; GENE CONSTRUCT; GENE THERAPY; IMAGING SYSTEM; IMMUNE DEFICIENCY; IN VIVO STUDY; MARKER GENE; MOUSE; NON INVASIVE MEASUREMENT; NONHUMAN; OVARY CANCER; PERITONEUM TUMOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR XENOGRAFT; VIRUS INFECTIVITY;

EID: 0037094237     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/94.10.741     Document Type: Article

References (47)

1. A controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer
2. Thymidine kinase gene therapy for human malignant glioma, using replication-deficient retroviruses or adenoviruses
3. Adenovirus-mediated p53 gene transfer in sequence with cisplatin to tumors of patients with non-small-cell lung cancer
4. Angiogenesis and vasculogenesis as therapeutic strategies for postnatal neovascularization
5. Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease
6. Evidence for gene transfer and expression of factor IX in haemophilia B patients treated with an AAV vector
7. Adenoviral-mediated suicide gene therapy for ovarian cancer
8. Thymidine kinase gene therapy with concomitant topotecan chemotherapy for recurrent ovarian cancer
9. HCAR and MCAR: The human and mouse cellular receptors for subgroup C adenoviruses and group B coxsackieviruses
10. An adenovirus vector with genetically modified fibers demonstrates expanded tropism via utilization of a coxsackievirus and adenovirus receptor-independent cell entry mechanism
11. Selectivity of TAG-72 targeted adenovirus gene transfer to primary ovarian carcinoma cells versus autologous mesothelial cells in vitro
12. An advanced generation of adenoviral vectors selectively enhances gene transfer for ovarian cancer gene therapy approaches
13. Detection of coxsackie-adenovirus receptor (CAR) immunoreactivity in ovarian tumors of epithelial derivation
14. Differential susceptibility of primary and established human glioma cells to adenovirus infection: Targeting via the epidermal growth factor receptor achieves fiber receptor-independent gene transfer
15. Selective gene delivery to head and neck cancer cells via an integrin targeted adenoviral vector
16. Loss of adenoviral receptor expression in human bladder cancer cells: A potential impact on the efficacy of gene therapy
17. Transduction efficiency of adenoviral vectors in colorectal cancer cells is determined by the presence of the coxsackie adenovirus receptor
18. Coxsackie adenovirus receptor immunohistochemical staining in superficial bladder tumors
19. The presence of human coxsackievirus and adenovirus receptor is associated with efficient adenovirus-mediated transgene expression in human melanoma cell cultures
20. Trans-complementation of vector replication versus Coxsackie-adenovirus-receptor overexpression to improve transgene expression in poorly permissive cancer cells
21. Fiber knob modifications overcome low, heterogeneous expression of the coxsackie-adenovirus receptor that limits adenovirus gene transfer and oncolysis for human rhabdomyosarcoma cells
22. The dual impact of coxsackie and adenovirus receptor expression on human prostate cancer gene therapy
23. Inhibition of the MAPK pathway up-regulates the human coxsackie and adenovirus receptor (CAR) and increases the infectivity of cancer cells with adenovirus
24. The mechanism of the growth-inhibitory effect of coxsackie and adenovirus receptor (CAR) on human bladder cancer: A functional analysis of CAR protein structure
25. Lack of high affinity fiber receptor activity explains the resistance of ciliated airway epithelia to adenovirus infection
26. Basolateral localization of fiber receptors limits adenovirus infection from the apical surface of airway epithelia
27. Modification of the genetic program of human alveolar macrophages by adenovirus vectors in vitro is feasible but inefficient, limited in part by the low level of expression of the coxsackie/adenovirus receptor
28. Transgenic expression of the coxsackie/adenovirus receptor enables adenoviral-mediated gene delivery in naive T cells
29. Muscle-specific overexpression of the adenovirus primary receptor CAR overcomes low efficiency of gene transfer to mature skeletal muscle
30. A cancer gene therapy approach utilizing an anti-erbB-2 single-chain antibody-encoding adenovirus (AD21): A phase I trial
31. Multi-dose intraperitoneal Rad/p53 (SCH58500) gene replacement combined with chemotherapy in heavily pretreated recurrent ovarian cancer is associated with prolonged survival
32. Phase I intraperitoneal p53 gene transfer in ovarian cancer
33. Using a tropism-modified adenoviral vector to circumvent inhibitory factors in ascites fluid
34. Neutralisation of adenovirus infectivity by ascitic fluid from ovarian cancer patients
35. An adenovirus with enhanced infectivity mediates molecular chemotherapy of ovarian cancer cells and allows imaging of gene expression
36. Expression of alpha(v)beta3 integrin is less frequent in ovarian epithelial tumors of low malignant potential in contrast to ovarian carcinomas
37. Expression and function of beta 1 and alpha v beta 3 integrins in ovarian cancer
38. Improved gene transfer efficiency to primary and established human pancreatic carcinoma target cells via epidermal growth factor receptor and integrin-targeted adenoviral vectors
39. Combined targeting of adenoviruses to integrins and epidermal growth factor receptors increases gene transfer into primary glioma cells and spheroids
40. Detection and measurement of in vitro gene transfer by gamma camera imaging
41. Noninvasive monitoring of gene transfer using a reporter receptor imaged with a high-affinity peptide radiolabeled with 99mTc or 188Re
42. Targeting adenovirus to the serotype 3 receptor increases gene transfer efficiency to ovarian cancer cells
43. Update on adenovirus and its vectors
44. Adenoviruses in oncology: A viable option?
45. Adenoviral-mediated delivery of herpes simplex virus thymidine kinase results in tumor reduction and prolonged survival in a SCID mouse model of human ovarian carcinoma
46. Adenovirus-mediated soluble FLT-1 gene therapy for ovarian carcinoma
47. Epithelial ovarian carcinoma